Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 37, 2002 - Issue 7
Submit an article Journal homepage
31
Views
28
CrossRef citations to date
0
Altmetric
Research Article

GI Cancer High Prevalence of Epstein-Barr Virus in Gastric Remnant Carcinoma after Billroth-II Reconstruction

J. Nishikawa
,
H. Yanai
,
A. Hirano
,
T. Okamoto
,
H. Nakamura
,
K. Matsusaki
,
T. Kawano
,
O Miura
&
K. Okita
 show all
Pages 825-829 | Published online: 08 Jul 2009

  • Rickinson AB, Kieff E. Epstein-Barr viras. In: Fields BN, Knipe DM, Howley PM, et al., editors. Fields virology, 3rd ed. Philadelphia: Lippincott-Raven; 1996. p. 2397-446.
  • Burke AP, Yen TS, Shekitka KM, Sobin LH. Lymphoepithelial carcinoma of the stomach with Epstein-Barr viras demonstrated by polymerase chain reaction. Mod Pathol 1990;3:377-80.
  • Shibata D, Weiss LM. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992;140:769-74.
  • Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E. Epstein-Barr viras in gastric carcinoma. Am J Pathol 1993; 143:1250-4.
  • Rowlands DC, Ito M, Mangham DC, Reynolds G, Herbst H, Hallissey MT, et al. Epstein-Barr virus and carcinomas: rare association of the viras with gastric carcinomas. Br J Cancer 1993;68:1014-9.
  • Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, et al. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr viras latent infection protein. Proc Natl Acad Sci USA 1994;91:9131-5.
  • Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba T, Takizawa T, et al. Epstein-Barr virus-associated gastric carcinoma: Epstein-Barr viras infection of the stomach. Lab Invest 1994;71:73-81.
  • Yoshiyama H, Imai S, Shimizu N, Takada K. Epstein-Barr viras infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol 1997;71:5688-91.
  • Imai S, Nishikawa J, Takada K. Cell to cell contact as an efficient mode of Epstein-Barr viras infection of diverse human epithelial cells. J Virol 1998;72:4371 -8.
  • Nishikawa J, Imai S, Oda T, Kojima T, Okita K, Takada K. Epstein-Barr viras promotes epithelial growth in the absence of EBNA2 and LMP1 expression. J Virol 1999;73:1286-92.
  • Caygill CP, Hill MJ, Kirkham JS, Northfield TC. Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet 1986;1:929-31.
  • Viste A, Bjornestad E, Opheim P, Skarstein A, Thunold J, Hartveit F, et al. Risk of carcinoma following gastric operations for benign disease: a historical cohort study of 3470 patients. Lancet 19862;502-5.
  • Toftgaard C. Gastric cancer after peptic ulcer surgery. A historic prospective cohort investigation. Ann Surg 1989;210:159-64.
  • Lundegardh G, Adami HO, Helmick C, Zack M, Meirik O. Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med 1988;319:195-200.
  • O'Connor HJ, Dixon MF, Wyatt JI, Axon AT, Ward DC, Dewar EP, et al. Effect of duodenal ulcer surgery and enterogastric reflux on campylobacter pyloridis. Lancet 1986;22:1178-81.
  • Miwa K, Hattori T, Miyazaki I. Duodenogastric reflux and foregut carcinogenesis. Cancer 1995;75:1426-32.
  • Tomtitchong P, Onda M, Matsukura N, Tokunaga A, Kato S, Matsuhisa T, et al. Helicobacter pylori infection in the remnant stomach after gastrectomy: with special reference to the difference between Billroth I and II anastomoses. J Clin Gastroenterol 1998;27:S154-8.
  • Yamamoto N, Tokunaga M, Uemura Y, Tanaka S, Shirahama H, Nakamura T, et al. Epstein-Barr virus and gastric remnant cancer. Cancer 1994;74:805-9.
  • Baas IO, van Rees BP, Musler A, Craanen ME, Tytgat GN, van den Berg FM, et al. Helicobacter pylori and Epstein-Barr virus infection and the p53 tumor suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach. J Clin Pathol 1998;51:662-6.
  • Chang MS, Lee JH, Kim JP, Kim HS, Lee HS, Kim CW, et al. Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers. Pathol Int 2000;50:486-92.
  • Japanese Research Society for Gastric Cancer. Handling of Specimen. In: Japanese classification of gastric carcinoma, 1st English ed. Tokyo: Kanehara & Co., Ltd; 1995. p. 66-71.
  • Dixon MF, Genta RM, Yardley JH, Correa P, and the Participants in the International Workshop on Histopathology of Gastritis, Houston 1994. Classification and grading of gastritis: the Updated Sydney System. Am J Surg Pathol 1996;20:1161-81.
  • Baas IO, Mulder JW, Offerhaus GJ, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
  • Watanabe H, Enjouji M, Imai T. Gastric carcinoma with lymphoid stroma. Cancer 1979;38:232-43.
  • Yanai H, Nishikawa J, Mizugaki Y, Shimizu N, Takada K, Matsusaki K, et al. Endoscopie and pathologic features of Epstein-Barr vims-associated gastric carcinoma. Gastrointest Endosc 1997;39:62-7.
  • Nishidoi H, Koga S, Kaibara N. Possible role of duodenogastri c reflux on the development of remnant gastric carcinoma induced by N-methyl-N'-nitro-N-nitrosoguanidin e in rats. JNCI 1984;72:1431-5.
  • Offerhaus GJ, Tersmette AC, Huibregtse K, van de Stadt J, Tersmette KW, Stijnen T, et al. Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions : 40 years of follow-up of an Amsterdam cohort of 2633 postgastrectomy patients. Gut 1988;29:1588-90.
  • Filipe MI, Munoz N, Matko I, Kalo I, Pompe-Kirn V, Jutersek A, et al. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 1994;57:324-9.
  • Stael von Holstein C, Hammar E, Eriksson S, Huldt B. Clinical significance of dysplasia in gastric remnant biopsy specimens. Cancer 1993;72:1532-5.
  • Yanai H, Murakami T, Yoshiyama H, Takeuchi H, Nishikawa J, Nakamura H, et al. Epstein-Barr virus-associated gastric carcinoma and chronic gastritis. J Clin Gastroenterol 1999;29:39-43.
  • Teramoto N, Maeda A, Kobayashi K, Hayashi K, Oka T, Takahashi K, et al. Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity. Lab Invest. 2000;80:303-12.
  • Tanigawa H, Uesugi H, Mitomi H, Saigenji K, Okayasu I. Possible association of active gastritis, featuring accelerated cell turnover and p53 overexpression, with cancer development at anastomoses after gastrojejunostomy. Am J Clin Pathol 2000; 114:354-63.
  • Clarice MR, Safatle-Ribeiro AV, Ribeiro U, Sakai P, Reynolds JC. bcl-2 protein expression in gastric remnant mucosa and gastric cancer 15 or more years after partial gastrectomy. Mod Pathol 1997;10:1021-7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.